INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 11, 2005 |
Director
Trans History: 466
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 23,000 |
| Jan 05, 2005 |
VP, Regulatory Development
Trans History: 288
|
VP, Regulatory Development | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 20,000 | -- | -- |
| Oct 13, 2004 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $4.25 | 31,391 |
| Oct 13, 2004 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Open market or private sale of non-derivative or derivative security | 20,000 | $8.00 | 11,391 |
| Oct 13, 2004 |
SVP, Manuf & Process Sciences
Trans History: 109
|
SVP, Manuf & Process Sciences | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 30,000 |
| May 05, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $7.44 | 32,530 |
| May 05, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Open market or private sale of non-derivative or derivative security | 20,000 | $13.50 | 12,530 |
| May 05, 2004 |
VP Clinical Programs
Trans History: 37
|
VP Clinical Programs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 15,000 |
| Feb 03, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 20,023 | $281.14 | 16,034,304 |
| Oct 15, 2014 |
Ten Percent Owner
Trans History: 555
|
Ten Percent Owner | Form 4 | Open market or private purchase of non-derivative or derivative security | 20,062 | $329.79 | 22,518,168 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.